Title: Emerging Indian entrepreneurship in biotechnology and National Innovation System: exploring linkages and prospects

Authors: Sachin Chaturvedi

Addresses: MacMillan Center for International Affairs, Yale University, New Haven, Connecticut 06520-8261, USA

Abstract: The recent expansion of Indian biotechnology industry backed by strong R&D allocations sets the upward movement of the industry on a new growth trajectory intertwined with innovation and entrepreneurship. This is most likely to take off Indian biopharma industry from |bio-generics| and |bio-similars| to a higher pedestal where it may develop |proprietary processes|, carving a new niche for the growth of the sector, giving further push to R&D-intensive activities. The issue is how National Innovation System (NIS), which could provide initial manpower and financial support to the sector, responds to the growing specialisation of the Indian biopharma and help evolve new strategies to sustain the growth in the high-end biopharma sector.

Keywords: India; biopharma; NIS; national innovation systems; biotechnology; Indian entrepreneurship; R&D investment; research and development; biopharmaceuticals.

DOI: 10.1504/IJTG.2010.033667

International Journal of Technology and Globalisation, 2010 Vol.5 No.1/2, pp.76 - 92

Available online: 15 Jun 2010 *

Full-text access for editors Access for subscribers Purchase this article Comment on this article